里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-005036 size: 8 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) sc 13g/a [amend] statement of acquisition of beneficial ownership by individuals accession number: 0001306550-23-007789 act: 34 size: 13 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-004731 size: 4 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-004732 size: 4 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-004733 size: 4 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-003441 size: 9 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-003443 size: 5 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-003442 size: 5 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 4 statement of changes in beneficial ownership of securities accession number: 0001140361-23-003439 size: 9 kb 网页链接
里格尔制药(rigl)：
里格尔制药(rigl) 8-k current report, item 5.02 accession number: 0001104659-23-010536 act: 34 size: 201 kb 网页链接
